---
layout: splash
title: SK바이오사이언스 (302440)
excerpt: SK바이오사이언스의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSPI
- P:의약품
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 64,900 | <span style="color: tomato">0.2<small>%</small></span> | P:의약품 | 40.7 | 2.9 | - |

<!-- more -->

<br>
> **기업 개요**<a id="company"></a>

섹터: 기초 의약물질 및 생물학적 제제 제조업  산업: 백신 제품 및 제제  상장일: 2021-03-18 00:00:00  결산월: 12월  대표자: 안재용  홈페이지: http://www.skbioscience.com  {: .notice}

<br>
> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 02&#x2011;08 | | [지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240208001010){:target="_blank"} |
| 02&#x2011;01 | | [연결재무제표기준영업(잠정)실적(공정공시)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240201800448){:target="_blank"} |
|  | | [기업설명회(IR)개최(안내공시)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240201800396){:target="_blank"} |
|  | | [매출액또는손익구조30%(대규모법인은15%)이상변경](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240201800374){:target="_blank"} |

<br>
> **주가 흐름**<a id="price"></a>

![302440](/stock/images/302440.png){: .align-center}

<br>
> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 64,900 | <span style="color: tomato">0.2<small>%</small></span> | <span style="color: tomato">1.2<small>%</small></span> | <span style="color: cornflowerblue">-4.8<small>%</small></span> | <span style="color: tomato">1.1<small>%</small></span> | <span style="color: cornflowerblue">-21.3<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: cornflowerblue">-16.7<small>%</small></span> | 40.8<small>%</small> | -0.41 | -31.9<small>%</small> | -13.6<small>%</small> | 0.5 |

<br>
> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| P:의약품 | 40.7 | 2.9 | - | - |

<br>
> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/302440/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=302440){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A302440&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=302440){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/302440){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/302440/financial-summary){:target="_blank"} |

<br>
> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![302440](/stock/images/302440_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | -16.7<small>%</small> | 40.8<small>%</small> | -0.41 | -31.9<small>%</small> | -13.6<small>%</small> |
| 적립식[^fn_tech_metric_dca] | -9.3<small>%</small> | 40.2<small>%</small> | -0.23 | -32.2<small>%</small> | -13.3<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | -12.2<small>%</small> | 27.9<small>%</small> | -0.44 | -26.7<small>%</small> | -13.1<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | -11.2<small>%</small> | 31.1<small>%</small> | -0.36 | -18.9<small>%</small> | -10.8<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | -25.0<small>%</small> | 26.5<small>%</small> | -0.94 | -32.4<small>%</small> | -20.6<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | -21.8<small>%</small> | 23.3<small>%</small> | -0.94 | -27.1<small>%</small> | -17.9<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | -25.0<small>%</small> | 22.1<small>%</small> | -1.13 | -27.0<small>%</small> | -16.8<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | -6.2<small>%</small> | 7.9<small>%</small> | -0.79 | -7.8<small>%</small> | -3.6<small>%</small> |
| MACD[^fn_tech_metric_macd] | -16.9<small>%</small> | 29.9<small>%</small> | -0.57 | -27.3<small>%</small> | -16.3<small>%</small> |

<br>
> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![302440](/stock/images/302440_corr.png){: .align-center}

|       | [효성첨단소재](/298050/) | [SK이노베이션](/096770/) | [LG이노텍](/011070/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [이녹스첨단소재](/272290/) | [에스에프에이](/056190/) | [씨에스윈드](/112610/) |

<br>
> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![302440](/stock/images/302440_2x.png){: .align-center}

<br>
> **관련 정보**

- [P:의약품 업종 목록](/stats/sector/kospi_업종_의약품_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}